Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A de Graeff

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|May 1, 1997
Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive ratsY M Pinto, H Buikema, W H van Gilst, et al.
Blood Pressure Monitoring|August 18, 1999
Home blood pressure measurement: reproducibility and relationship with left ventricular massR H Kok, F W Beltman, W F Terpstra, et al.
European Heart Journal|March 14, 2003
Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trialH L Hillege, W H van Gilst, D J van Veldhuisen, et al.
International Journal of Cardiology|June 15, 1994
Lipoprotein(a) levels in patients with myocardial infarction treated with anistreplase: no prediction of efficacy but inverse correlation with plasminogen activation in non-patencyJ Brügemann, J van der Meer, H L Hillege, et al.
Journal of Cardiac Failure|October 23, 1997
Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failureS A van den Broek, P A de Graeff, D J van Veldhuisen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 1, 1993
Mode of death in patients with congestive heart failure: comparison between possible candidates for heart transplantation and patients with less advanced diseaseS A van den Broek, D J van Veldhuisen, P A de Graeff, et al.
European Journal of Clinical Pharmacology|February 24, 2001
Predictors for prophylactic antithrombotic prescribing in ischaemic heart disease and the impact of national guidelinesR Fijn, A G Stuurman-Bieze, P B van den Berg, et al.
Clinical Pharmacology and Therapeutics|April 5, 2012
Impact of safety-related regulatory action on drug use in ambulatory care in the NetherlandsS Piening, K C Reber, J E Wieringa, et al.
Journal of Cardiovascular Pharmacology|March 1, 1992
Effects of early angiotensin-converting enzyme inhibition in a pig model of myocardial ischemia and reperfusionJ van Wijngaarden, T J Tobé, E G Weersink, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1992
Late potentials in a porcine model of anterior wall myocardial infarction and their relation to inducible ventricular tachycardiaT J Tobé, C D de Langen, P H Mook, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Journal of Molecular Medicine (Berlin, Germany)|May 1, 1997
Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive ratsY M Pinto, H Buikema, W H van Gilst, et al.
Blood Pressure Monitoring|August 18, 1999
Home blood pressure measurement: reproducibility and relationship with left ventricular massR H Kok, F W Beltman, W F Terpstra, et al.
European Heart Journal|March 14, 2003
Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trialH L Hillege, W H van Gilst, D J van Veldhuisen, et al.
International Journal of Cardiology|June 15, 1994
Lipoprotein(a) levels in patients with myocardial infarction treated with anistreplase: no prediction of efficacy but inverse correlation with plasminogen activation in non-patencyJ Brügemann, J van der Meer, H L Hillege, et al.
Journal of Cardiac Failure|October 23, 1997
Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failureS A van den Broek, P A de Graeff, D J van Veldhuisen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 1, 1993
Mode of death in patients with congestive heart failure: comparison between possible candidates for heart transplantation and patients with less advanced diseaseS A van den Broek, D J van Veldhuisen, P A de Graeff, et al.
European Journal of Clinical Pharmacology|February 24, 2001
Predictors for prophylactic antithrombotic prescribing in ischaemic heart disease and the impact of national guidelinesR Fijn, A G Stuurman-Bieze, P B van den Berg, et al.
Clinical Pharmacology and Therapeutics|April 5, 2012
Impact of safety-related regulatory action on drug use in ambulatory care in the NetherlandsS Piening, K C Reber, J E Wieringa, et al.
Journal of Cardiovascular Pharmacology|March 1, 1992
Effects of early angiotensin-converting enzyme inhibition in a pig model of myocardial ischemia and reperfusionJ van Wijngaarden, T J Tobé, E G Weersink, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1992
Late potentials in a porcine model of anterior wall myocardial infarction and their relation to inducible ventricular tachycardiaT J Tobé, C D de Langen, P H Mook, et al.
Pageof 9